Enhancing blood test accuracy using new technology
Improving ELISA Technology using Ultra-efficient Peroxidase Mimics
['FUNDING_R01'] · UNIVERSITY OF CENTRAL FLORIDA · NIH-11055328
This study is exploring a new way to make blood tests for conditions like cancer more accurate and sensitive by using tiny particles that act like enzymes, which could help doctors catch diseases earlier.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CENTRAL FLORIDA (nih funded) |
| Locations | 1 site (ORLANDO, UNITED STATES) |
| Trial ID | NIH-11055328 on ClinicalTrials.gov |
What this research studies
This research focuses on improving the enzyme-linked immunosorbent assay (ELISA) technology, which is commonly used for diagnosing various conditions, including cancer. The study aims to develop a new method using nanoparticles that can mimic the action of enzymes, significantly increasing the sensitivity and accuracy of blood tests. By utilizing these nanoparticles, the researchers hope to achieve better detection limits for biomarkers, which could lead to earlier diagnosis of diseases. This innovative approach could transform how blood tests are conducted in clinical settings.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who require blood tests for the detection of biomarkers related to cancer or other serious conditions.
Not a fit: Patients who do not require blood tests or those with conditions that are not detectable through biomarkers may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and earlier detection of diseases, particularly cancers, improving patient outcomes.
How similar studies have performed: Other research has shown promise in using nanoparticles for enhancing diagnostic tests, indicating that this approach could be a significant advancement in the field.
Where this research is happening
ORLANDO, UNITED STATES
- UNIVERSITY OF CENTRAL FLORIDA — ORLANDO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: XIA, XIAOHU — UNIVERSITY OF CENTRAL FLORIDA
- Study coordinator: XIA, XIAOHU
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.